CompletedInterventionalPhase 3Updated Jan 31, 2013
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer | NCT00540280 | Trialant
SuspendedInterventionalPhase 3Updated Mar 8, 2011
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
ClinicalTrials.gov ID
NCT00540280
Lead Sponsor
King Faisal Specialist Hospital & Research CenterOTHER
Overall Status
Suspended
Study Type
Interventional
Phase
Phase 3
Enrollment
10Estimated
Last Update Posted
Mar 8, 2011Estimated
Start Date
Oct 2003
Primary Completion Date
Oct 2003Estimated
Completion Date
Oct 2013Estimated
Brief Summary
Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer
Carcinoma, Non-Small-Cell Lung
Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with early stage NSCLC
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
No locations
There are no locations for this study.
Lead Sponsor
King Faisal Specialist Hospital & Research CenterOTHER